-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 5, Haisco announced that the company intends to sign a "technology transfer contract" with the company’s fourth-tier subsidiary HAISCO PHARMACEUTICALS PTE.
Haisco stated that the company sold the proprietary technology of four projects of DPP1 inhibitor, EZH1/2 dual-target inhibitor, JAK inhibitor and Nrf2 agonist drugs in markets outside the Chinese mainland (including Hong Kong, Macau and Taiwan) to the Singapore company for the purpose of Better promote the overseas operation and development of the company's innovative drug research projects